Control and Elimination of Plasmodium vivax

Advances in Parasitology

Volumn 80, Issue , 2012, Pages 301-341

  Shanks, G Dennis ^a,b  

^a AUSTRALIAN ARMY MALARIA INSTITUTE   (Australia)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Malaria elimination; Mass drug administration; Plasmodium vivax; Primaquine; Tafenoquine

Indexed keywords

8 AMINOQUINOLINE DERIVATIVE; AMODIAQUINE; ANTIMALARIAL AGENT; ARTEMISININ; CHLOROQUINE; INSECTICIDE; MALARIA VACCINE; METHYLENE BLUE; PRIMAQUINE; PYRIMETHAMINE PLUS SULFADOXINE; QUININE; TAFENOQUINE;

AFRICA; ANOPHELES; ARTICLE; BED NET; DIAGNOSTIC TEST; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; GENETIC POLYMORPHISM; GEOGRAPHIC DISTRIBUTION; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEALTH SURVEY; HEMOLYSIS; HUMAN; HYPNOZOITE; IMIDAZOLIDINEDIONE DERIVATIVE; IMMUNIZATION; KOREA; LOW TEMPERATURE; MALARIA CONTROL; MALARIA FALCIPARUM; MEXICO; MICROSCOPY; PLASMODIUM; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PRIORITY JOURNAL; RELAPSE; SOLOMON ISLANDS; TAIWAN; TINNITUS;

EID: 84870317603     PISSN: 0065308X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-397900-1.00006-2     Document Type: Chapter

References (170)

1. Abilio A.P., Kleinschmidt I., Rehman A.M., Cuamba N., Ramdeen V., Mthembu D.S., et al. The emergence of insecticide resistance in central Mozambique and potential threat to the successful indoor residual spraying malaria control programme. Malar. J. 2011, 10:110.
2. Adjalley S.H., Johnston G.L., Li T., Eastman R.T., Ekland E.H., Eappen A.G., et al. Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue. Proc. Natl. Acad. Sci. U S A 2011, 108(47):E1214-E1223.
3. Aguas R., White L.J., Snow R.W., Gomes M.G. Prospects for malaria eradication in sub-Saharan Africa. PloS One 2008, 3(3):e1767.
4. Alving A.S., Arnold J., Robinson D.H. Mass therapy of subclinical vivax malaria with primaquine. J. Am. Med. Assoc. 1952, 149(17):1558-1562.
5. Alving A.S., Johnson C.F., Tarlov A.R., Brewer G.J., Kellermeyer R.W., Carson P.E. Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Piasmodium vivax by intermittent regimens of drug administration: a preliminary report. Bull. World Health Organ. 1960, 22:621-631.
6. Amangel'diev K.A., Morozova K.V., Medalieva D.O. The epidemic situation with malaria in Turkmenistan. Meditsinskaia Parazitologiia I Parazitarnye Bolezni 2000, 2:29-32. Epidemicheskaia situatsiia po maliarii v Turkmenistane.
7. Andrews J.M., Quinby G.E., Langmuir A.D. Malaria eradication in the United States. Am. J. Public Health Nations Health 1950, 40(11):1405-1411.
8. Archambeault C. Mass antimalarial therapy in veterans returning from Korea. J. Am. Med. Assoc. 1954, 154(17):1411-1415.
9. Armengaud A., Legros F., D'Ortenzio E., Quatresous I., Barre H., Houze S., et al. A case of autochthonous Plasmodium vivax malaria, Corsica, August 2006. Travel Med. Infect. Dis. 2008, 6(1-2):36-40.
10. Ashley E.A., Touabi M., Ahrer M., Hutagalung R., Htun K., Luchavez J., et al. Evaluation of three parasite lactate dehydrogenase-based rapid diagnostic tests for the diagnosis of falciparum and vivax malaria. Malar. J. 2009, 8:241.
11. Ashton R.A., Kefyalew T., Tesfaye G., Counihan H., Yadeta D., Cundill B., et al. Performance of three multi-species rapid diagnostic tests for diagnosis of Plasmodium falciparum and Plasmodium vivax malaria in Oromia Regional State, Ethiopia. Malar. J. 2010, 9:297.
12. Ashton R.A., Kefyalew T., Tesfaye G., Pullan R.L., Yadeta D., Reithinger R., et al. School-based surveys of malaria in Oromia Regional State, Ethiopia: a rapid survey method for malaria in low transmission settings. Malar. J. 2011, 10(1):25.
13. Avery J.G. A review of the malaria eradication programme in the British Solomon Islands 1970-72. P. N. G. Med. J. 1973, 17(1):50-67.
14. Avery J. The Epidemiology of Disappearing Malaria in the Solomon Islands 1977, University of Sheffield, Sheffield UK.
15. Baeza J. Partial control of malaria in a localized area by plasmoquine. J. Malaya Branch Br. Med. Assoc. 1939, 2(4):239-243.
16. Baird J.K. Resistance to therapies for infection by Plasmodium vivax. Clin. Microbiol. Rev. 2009, 22(3):508-534.
17. Baranova A.M., Sergiev V.P. The malaria situation in the Russian Federation (1997-1999). Meditsinskaia Parazitologiia I Parazitarnye Bolezni 2000, (2):22-25. Situatsiia po maliarii v Rossiiskoi Federatsii (1997-1999 gody).
18. Barber M., Komp W., Newman B. The effect of small doses of Plasmochin on the viability of gametocytes of malaria as measured by mosquito infection experiments. Public Health Rep. 1929, 44:1409-1420.
19. Barber M., Rice J., Brown O. Malaria studies on the Fireston rubber plantation in Liberia, West Africa. Am. J. Hyg. 1932, 15:601-633.
20. Bismil'din F.B., Shapieva Z., Anpilova E.N. Current malaria situation in the Republic of Kazakhstan. Meditsinskaia parazitologiia i parazitarnye bolezni 2001, (1):24-33.
21. Black R. Malaria in the British Solomon Islands Protectorate. Noumea: South Pacific Comm, Tech paper 33. 1952.
22. Blossom D., King C.H., Armitage K. Occult Plasmodium vivax infection diagnosed by a polymerase chain reaction-based detection system: a case report. Am. J. Trop. Med. Hyg. 2005, 73(1):188-190.
23. Borrmann S., Matuschewski K. Targeting Plasmodium liver stages: better late than never. Trends Mol. Med. 2011, 17(9):527-536.
24. Bountogo M., Zoungrana A., Coulibaly B., Klose C., Mansmann U., Mockenhaupt F.P., et al. Efficacy of methylene blue monotherapy in semi-immune adults with uncomplicated falciparum malaria: a controlled trial in Burkina Faso. Trop. Med. Int. Health: TM & IH 2010, 15(6):713-717.
25. Breman J.G., de Quadros C.A., Dowdle W.R., Foege W.H., Henderson D.A., John T.J., et al. The role of research in viral disease eradication and elimination programs: lessons for malaria eradication. PLoS Med. 2011, 8(1):e1000405.
26. Brooke B.D., Hunt R.H., Chandre F., Carnevale P., Coetzee M. Stable chromosomal inversion polymorphisms and insecticide resistance in the malaria vector mosquito Anopheles gambiae (Diptera: Culicidae). J. Med. Entomol. 2002, 39(4):568-573.
27. Brown P.J. Failure-as-success: multiple meanings of eradication in the Rockerfeller Foundation Sardinia project, 1946-1951. Parassitologia 1998, 40:117-130.
28. Bruce-Chwatt L.J., Bruce-Chwatt J.M. Malaria in Mauritius-as dead as the dodo. Bull. N. Y. Acad. Med. 1974, 50(10):1069-1080.
29. Bruce-Chwatt L.J. The role of drugs in a malaria program. Am. J. Trop. Med. Hyg. 1972, 21(5):731-735.
30. Bruce-Chwatt L.J. Malaria eradication in Portugal. Trans. R. Soc. Trop. Med. Hyg. 1977, 71(3):232-240.
31. Cappellini M.D., Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet 2008, 371:64-74.
32. Chanda E., Hemingway J., Kleinschmidt I., Rehman A.M., Ramdeen V., Phiri F.N., et al. Insecticide resistance and the future of malaria control in Zambia. PloS One 2011, 6(9):e24336.
33. Chen W.I. Malaria eradication in Taiwan, 1952-1964-some memorable facts. Gaoxiong Yi Xue Ke Xue Za Zhi (The Kaohsiung Journal of Medical Sciences) 1991, 7(5):263-270.
34. Choi Y.K., Choi K.M., Park M.H., Lee E.G., Kim Y.J., Lee B.C., et al. Rapid dissemination of newly introduced Plasmodium vivax genotypes in South Korea. Am. J. Trop. Med. Hyg. 2010, 82(3):426-432.
35. Clark H., Komp W., Jobbins D. A tenth year's observations on malaria in Panama, with reference to the occurrence of variations in the parasite index, during continued treatment with atabrine and plasmochine. Am. J. Trop. Med. 1942, 22:191-216.
36. Clayman C.B., Arnold J., Hockwald R.S., Yount E.H., Edgcomb J.H., Alving A.S. Toxicity of primaquine in Caucasians. J. Am. Med. Assoc. 1952, 149(17):1563-1568.
37. Clyde D.F. Mass administration of an antimalarial drug combining 4-aminoquinoline and 8-aminoquinoline in Tanganyika. Bull. World Health Organ. 1962, 27:203-212.
38. Coatney G.R., Alving A.S., Jones R., Hankey D.D., Robinson D.H., Garrison P.L., et al. Korean vivax malaria. V. Cure of the infection by primaquine administered during long-term latency. Am. J. Trop. Med. Hyg. 1953, 2(6):985-988.
39. Colbourne M.J. Prospects for malaria eradication, with special reference to the Western Pacific. Trans. R. Soc. Trop. Med. Hyg. 1962, 56:179-201.
40. Coulibaly B., Zoungrana A., Mockenhaupt F.P., Schirmer R.H., Klose C., Mansmann U., et al. Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial. PloS One 2009, 4(5):e5318.
41. Crichlow N. The prevalent diseases of the British Solomon Islands. Trans. R. Soc. Trop. Med. Hyg. 1929, 23(2):179-184.
42. Cui L., Yan G., Sattabongkot J., Chen B., Cao Y., Fan Q., et al. Challenges and prospects for malaria elimination in the greater Mekong Subregion. Acta. Trop. 2011.
43. Culleton R., Ndounga M., Zeyrek F.Y., Coban C., Casimiro P.N., Takeo S., et al. Evidence for the transmission of Plasmodium vivax in the Republic of the Congo, West Central Africa. J. Infect. Dis. 2009, 200(9):1465-1469.
44. Danis K., Baka A., Lenglet A., Van Bortel W., Terzaki I., Tseroni M., et al. Autochthonous Plasmodium vivax malaria in Greece. Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles (European Communicable Disease Bulletin) 2011, 16(42).
45. Danis-Lozano R., Rodriguez M.H., Betanzos-Reyes A.F., Hernandez-Avila J.E., Gonzalez-Ceron L., Mendez-Galvan J.F., et al. Individual risk factors for Plasmodium vivax infection in the residual malaria transmission focus of Oaxaca, Mexico. Salud Publica De Mexico 2007, 49(3):199-209.
46. Dapeng L., Leyuan S., Xili L., Xiance Y. A successful control programme for falciparum malaria in Xinyang, China. Trans. R. Soc. Trop. Med. Hyg. 1996, 90(2):100-102.
47. Department of Health, Executive Yuan Malaria Eradication in Taiwan 1991, Taipei, Taiwan.
48. Derbyshire E.R., Mota M.M., Clardy J. The next opportunity in anti-malaria drug discovery: the liver stage. PLoS Pathog. 2011, 7(9):e1002178.
49. Doi H., Kaneko A., Panjaitan W., Ishii A. Chemotherapeutic malaria control operation by single dose of Fansidar plus primaquine in North Sumatra, Indonesia. Southeast Asian J. Trop. Med. Public Health 1989, 20(3):341-349.
50. Dola S. Mass drug administration as a supplementary attack measure in malaria eradication programme. East Afr. Med. J. 1974, 51(7):529-531.
51. Escudie A., Hamon J., Schneider J. Resultats d'une chimioprohylaxie antipaludique de masse par l'association amino-4-quinoleine/amino-8-quinoleine en milieu rural Africain de la region de Bobo-Dioulasso. Med. Trop. Mar-Apr 1962, 22:268-305.
52. Faust E.C., Scott J.A., Mc D.G. Malaria mortality and morbidity in the United States for the year 1945. J. Natl. Malar. Soc. 1947, 6(3):184-191.
53. Feachem R., Sabot O. A new global malaria eradication strategy. Lancet 2008.
54. Feachem R.G., Phillips A.A., Targett G.A., Snow R.W. Call to action: priorities for malaria elimination. Lancet 2010, 376(9752):1517-1521.
55. Field J., Niven J., Hodgkin E., Mitchell J. Field observations on the effects of prophylactic plasmoquine on the incidence, course, severity and transmission of P vivax malaria 1940, Kuala Lumpur: Contract No.: 3.
56. Ganczakowski M., Town M., Bowden D.K., Vulliamy T.J., Kaneko A., Clegg J.B., et al. Multiple glucose 6-phosphate dehydrogenase-deficient variants correlate with malaria endemicity in the Vanuatu archipelago (southwestern Pacific). Am. J. Hum. Genet. 1995, 56(1):294-301.
57. Garfield R.M., Vermund S.H. Changes in malaria incidence after mass drug administration in Nicaragua. Lancet 1983, 2(8348):500-503.
58. Garfield R.M., Prado E., Gates J.R., Vermund S.H. Malaria in Nicaragua: community-based control efforts and the impact of war. Int. J. Epidemiol. 1989, 18(2):434-439.
59. Garrison P.L., Hankey D.D., Coker W.G., Donovan W.N., Jastremski B., Coatney G.R., et al. Cure of Korean vivax malaria with pamaquine and primaquine. J. Am. Med. Assoc. 1952, 149(17):1562-1563.
60. Genton B., D'Acremont V., Rare L., Baea K., Reeder J.C., Alpers M.P., et al. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med. 2008, 5(6):e127.
61. Gething P.W., Smith D.L., Patil A.P., Tatem A.J., Snow R.W., Hay S.I. Climate change and the global malaria recession. Nature 2010, 465(7296):342-345.
62. Goodwin M.H. Observations on the recession of malaria in an area of southwestern Georgia. Am. J. Trop. Med. Hyg. 1950, 30(5):651-661.
63. Greenwood B. The use of anti-malarial drugs to prevent malaria in the population of malaria-endemic areas. Am. J. Trop. Med. Hyg. 2004, 70(1):1-7.
64. Greenwood B. Intermittent preventive antimalarial treatment in infants. Clin. Infect. Dis. 2007, 45(1):26-28.
65. Greenwood B. Progress in malaria control in endemic areas. Travel Med. Infect. Dis. 2008, 6(4):173-176.
66. Greenwood B.M. Control to elimination: implications for malaria research. Trends Parasitol. 2008, 24(10):449-454.
67. Guan J., Wang X., Smith K., Ager A., Gettayacamin M., Kyle D.E., et al. Malaria causal prophylactic activity of imidazolidinedione derivatives. J. Med. Chem. 2007, 50(24):6226-6231.
68. Guerra C.A., Howes R.E., Patil A.P., Gething P.W., Van Boeckel T.P., Temperley W.H., et al. The international limits and population at risk of Plasmodium vivax transmission in 2009. PLoS Negl. Trop. Dis. 2010, 4(8):e774.
69. Gunther C., Fraser N., Wright W. Proguanil and malaria among non-tolerant New Guinea natives. Trans. R. Soc. Trop. Med. Hyg. 1952, 46:185-200.
70. Gunther C.E. Proguanil hydrochloride (paludrine) in the prevention and treatment of malaria in New Guinea. Trans. R. Soc. Trop. Med. Hyg. 1951, 44(4):473-478.
71. Hall B.F., Fauci A.S. Malaria control, elimination, and eradication: the role of the evolving biomedical research agenda. J. Infect. Dis. 2009, 200(11):1639-1643.
72. Harris I., Sharrock W.W., Bain L.M., Gray K.A., Bobogare A., Boaz L., et al. A large proportion of asymptomatic Plasmodium infections with low and sub-microscopic parasite densities in the low transmission setting of Temotu Province, Solomon Islands: challenges for malaria diagnostics in an elimination setting. Malar. J. 2010, 9:254.
73. Hay S.I., Smith D.L., Snow R.W. Measuring malaria endemicity from intense to interrupted transmission. Lancet Infect. Dis 2008, 8(6):369-378.
74. Hii J.L., Vun Y.S., Chin K.F., Chua R., Tambakau S., Binisol E.S., et al. The influence of permethrin-impregnated bednets and mass drug administration on the incidence of Plasmodium falciparum malaria in children in Sabah, Malaysia. Med. Vet. Entomol. 1987, 1:397-407.
75. Hill E., Amatuzio D. Southwest Pacific vivax malaria; clinical features and observations concerning duration of clinical activity. Am. J. Trop. Med. Hyg. 1949, 29(2):203-214.
76. Hill D.R., Baird J.K., Parise M.E., Lewis L.S., Ryan E.T., Magill A.J. Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I. Am. J. Trop. Med. Hyg. 2006, 75(3):402-415.
77. Hockwald R.S., Arnold J., Clayman C.B., Alving A.S. Toxicity of primaquine in Negroes. J. Am. Med. Assoc. 1952, 149(17):1568-1570.
78. Howes R.E., Piel F.B., Patil A.P., Nyangiri O.A., Gething P.W., Dewi M., et al. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med. 2010, (in press).
79. Howes R.E., Patil A.P., Piel F.B., Nyangiri O.A., Kabaria C.W., Gething P.W., et al. The global distribution of the Duffy blood group. Nat. Comms. 2011, 2:266.
80. Hsiang M.S., Abeyasinghe R., Whittaker M., Feachem R.G. Malaria elimination in Asia-Pacific: an under-told story. Lancet 2010, 375(9726):1586-1587.
81. Hui F.M., Xu B., Chen Z.W., Cheng X., Liang L., Huang H.B., et al. Spatio-temporal distribution of malaria in Yunnan Province, China. Am. J. Trop. Med. Hyg. 2009, 81(3):503-509.
82. Jun G., Yeom J.S., Hong J.Y., Shin E.H., Chang K.S., Yu J.R., et al. Resurgence of Plasmodium vivax malaria in the Republic of Korea during 2006-2007. Am. J. Trop. Med. Hyg. 2009, 81(4):605-610.
83. Kaiser M.L., Koekemoer L.L., Coetzee M., Hunt R.H., Brooke B.D. Staggered larval time-to-hatch and insecticide resistance in the major malaria vector Anopheles gambiae S form. Malar. J. 2010, 9:360.
84. Kaiser R.L. Epidemiology of malaria eradication. 3. The role of surveillance in a malaria eradication program. Am. J. Public Health Nations Health 1966, 56(1):90-93.
85. Kaneko A., Taleo G., Kalkoa M., Yaviong J., Reeve P.A., Ganczakowski M., et al. Malaria epidemiology, glucose 6-phosphate dehydrogenase deficiency and human settlement in the Vanuatu Archipelago. Acta. Trop. 1998, 70(3):285-302.
86. Kaneko A., Taleo G., Kalkoa M., Yamar S., Kobayakawa T., Bjorkman A. Malaria eradication on islands. Lancet 2000, 356(9241):1560-1564.
87. Kaneko A.A. Community-directed strategy for sustainable malaria elimination on islands: short-term MDA integrated with ITNs and robust surveillance. Acta. Trop. 2010, 114(3):177-183.
88. Kappe S.H., Vaughan A.M., Boddey J.A., Cowman A.F. That was then but this is now: malaria research in the time of an eradication agenda. Science 2010, 328(5980):862-866.
89. Kasehagen L.J., Mueller I., Kiniboro B., Bockarie M.J., Reeder J.C., Kazura J.W., et al. Reduced Plasmodium vivax erythrocyte infection in PNG Duffy-negative heterozygotes. PloS One 2007, 2(3):e336.
90. Kere N.K., Parkinson A.D., Samrawickerema W.A. The effect of permethrin impregnated bednets on the incidence of Plasmodium falciparum, in children of north Guadalcanal, Solomon Islands. Southeast Asian J. Trop. Med. Public Health 1993, 24(1):130-137.
91. Kidson C., Indaratna K. Ecology, economics and political will: the vicissitudes of malaria strategies in Asia. Parassitologia 1998, 40(1-2):39-46.
92. Killeen G.F. Following in Soper's footsteps: northeast Brazil 63 years after eradication of Anopheles gambiae. Lancet Infect. Dis. 2003, 3(10):663-666.
93. Kim H.C., Pacha L.A., Lee W.J., Lee J.K., Gaydos J.C., Sames W.J., et al. Malaria in the Republic of Korea, 1993-2007. Variables related to re-emergence and persistence of Plasmodium vivax among Korean populations and U.S. forces in Korea. Mil. Med. 2009, 174(7):762-769.
94. Kingsbury A., Amies C. A field experiment on the value of plasmoquine in the prophylaxis of malaria. Trans. R. Soc. Trop. Med. Hyg. 1931, 25(3):159-172.
95. Klein T.A., Pacha L.A., Lee H.C., Kim H.C., Lee W.J., Lee J.K., et al. Plasmodium vivax malaria among U.S. forces Korea in the Republic of Korea, 1993-2007. Mil. Med. 2009, 174(4):412-418.
96. Kondrashin A.V., Sanyal M.C. Mass drug administration in Andhra Pradesh in areas under Plasmodium falciparum containment programme. J. Commun. Dis. 1985, 17(4):293-299.
97. Kouznetsov R.L. The place of chemotherapy in antimalaria programmes. WHO Chron. 1979, 33(1):9-12.
98. Kuwahata M., Wijesinghe R., Ho M.F., Pelecanos A., Bobogare A., Landry L., et al. Population screening for glucose-6-phosphate dehydrogenase deficiencies in Isabel Province, Solomon Islands, using a modified enzyme assay on filter paper dried bloodspots. Malar. J. 2010, 9:223.
99. Lell B., Faucher J.F., Missinou M.A., Borrmann S., Dangelmaier O., Horton J., et al. Malaria chemoprophylaxis with tafenoquine: a randomised study. Lancet 2000, 355(9220):2041-2045.
100. Lisansky E. The eradication of malaria as an endemic disease in the United States. Ann. Intern. Med. 1958, 48(2):428-438.
101. Luxemburger C., Perea W., Delmas G., Pruja C., Pecoul B., Moren A. Permethrin-impregnanted bed nets for the prevention of malaria in schoolchildren on the Thai-Burmese border. Trans. R. Soc. Trop. Med. Hyg. 1994, 88(2):155-159.
102. Ly A.B., Tall A., Perry R., Baril L., Badiane A., Faye J., et al. Use of HRP-2-based rapid diagnostic test for Plasmodium falciparum malaria: assessing accuracy and cost-effectiveness in the villages of Dielmo and Ndiop, Senegal. Malar. J. 2010, 9:153.
103. Macphail N. Plasmochin in malaria, 16th Annual Report of Medical Dept 1927, United Fruit Company, New York.
104. malERA A research agenda for malaria eradication: drugs. PLoS Med. 2011, 8(1):e1000402.
105. malERA A research agenda for malaria eradication: vector control. PLoS Med. 2011, 8(1):e1000401.
106. Malaria in the army in India. Lancet 1934, 223:802.
107. Marchi A., Munstermann L.E. The mosquitoes of Sardinia: species records 35 years after the malaria eradication campaign. Med. Vet. Entomol. 1987, 1(1):89-96.
108. Matthys B., Sherkanov T., Karimov S.S., Khabirov Z., Mostowlansky T., Utzinger J., et al. History of malaria control in Tajikistan and rapid malaria appraisal in an agro-ecological setting. Malar. J. 2008, 7:217.
109. Mayxay M., Pukrittayakamee S., Newton P.N., White N.J. Mixed-species malaria infections in humans. Trends Parasitol. 2004, 20(5):233-240.
110. Meissner P.E., Mandi G., Witte S., Coulibaly B., Mansmann U., Rengelshausen J., et al. Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841]. Malar. J. 2005, 4:45.
111. Meissner P.E., Mandi G., Coulibaly B., Witte S., Tapsoba T., Mansmann U., et al. Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine. Malar. J. 2006, 5:84.
112. Meister S., Plouffe D.M., Kuhen K.L., Bonamy G.M., Wu T., Barnes S.W., et al. Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery. Science 2011, 334(6061):1372-1377.
113. Mendes C., Dias F., Figueiredo J., Mora V.G., Cano J., de Sousa B., et al. Duffy negative antigen is no longer a barrier to Plasmodium vivax - molecular evidences from the African West Coast (Angola and Equatorial Guinea). PLoS Negl. Trop. Dis. 2011, 5(6):e1192.
114. Miller M. Suppression of malaria by monthly drug administration. Am. J. Trop. Med. Hyg. 1955, 4:790-799.
115. Miller M. Further studies on malaria suppression by monthly drug administration. Am. J. Trop. Med. Hyg. 1956, 5:624-637.
116. Moonen B., Cohen J.M., Snow R.W., Slutsker L., Drakeley C., Smith D.L., et al. Operational strategies to achieve and maintain malaria elimination. Lancet 2010, 376(9752):1592-1603.
117. Moss W.J., Norris D.E., Mharakurwa S., Scott A., Mulenga M., Mason P.R., et al. Challenges and prospects for malaria elimination in the Southern Africa region. Acta. Trop. 2011.
118. Nasveld P., Kitchener S., Edstein M., Rieckmann K. Comparison of tafenoquine (WR238605) and primaquine in the post-exposure (terminal) prophylaxis of vivax malaria in Australian Defence Force personnel. Trans. R. Soc. Trop. Med. Hyg. 2002, 96(6):683-684.
119. Oh M.D., Shin H., Shin D., Kim U., Lee S., Kim N., et al. Clinical features of vivax malaria. Am. J. Trop. Med. Hyg. 2001, 65(2):143-146.
120. Over M., Bakote'e B., Velayudhan R., Wilikai P., Graves P.M. Impregnated nets or DDT residual spraying? Field effectiveness of malaria prevention techniques in Solomon Islands, 1993-1999. Am. J. Trop. Med. Hyg. 2004, 71(Suppl. 2):214-223.
121. Park J.W., Jun G., Yeom J.S. Plasmodium vivax malaria: status in the Republic of Korea following reemergence. Korean J. Parasitol. 2009, (Suppl. 47):S39-S50.
122. Plowe C.V., Alonso P., Hoffman S.L. The potential role of vaccines in the elimination of falciparum malaria and the eventual eradication of malaria. J. Infect. Dis. 2009, 200(11):1646-1649.
123. Polley S.D., McRobert L., Sutherland C.J. Vaccination for vivax malaria: targeting the invaders. Trends Parasitol. 2004, 20(3):99-102.
124. Ponsa N., Sattabongkot J., Kittayapong P., Eikarat N., Coleman R.E. Transmission-blocking activity of tafenoquine (WR-238605) and artelinic acid against naturally circulating strains of Plasmodium vivax in Thailand. Am. J. Trop. Med. Hyg. 2003, 69(5):542-547.
125. Rajakaruna R.S., Alifrangis M., Amerasinghe P.H., Konradsen F. Pre-elimination stage of malaria in Sri Lanka: assessing the level of hidden parasites in the population. Malar. J. 2010, 9:25.
126. Ray A. Prophylactic use of paludrine in a tea estate. Indian J. Malariol. 1948, 2(1/2):35-66.
127. Razakov Sh A. The epidemic situation with malaria in Uzbekistan. Meditsinskaia Parazitologiia I Parazitarnye Bolezni 2000, (2):32-34. (Epidemicheskaia situatsiia po maliarii v Uzbekistane).
128. Reeve P.A., Toaliu H., Kaneko A., Hall J.J., Ganczakowski M. Acute intravascular haemolysis in Vanuatu following a single dose of primaquine in individuals with glucose-6-phosphate dehydrogenase deficiency. J. Trop. Med. Hyg. 1992, 95(5):349-351.
129. Rieckmann K.H., McNamara J.V., Frischer H., Stockert T.A., Carson P.E., Powell R.D. Gametocytocidal and sporontocidal effects of primaquine and of sulfadiazine with pyrimethamine in a chloroquine-resistant strain of Plasmodium falciparum. Bull. World Health Organ. 1968, 38(4):625-632.
130. Rieckmann K. Malaria Eradication Using Mass Drug Administration on Nissan Island in Papua New Guinea 1963, University of Sydney, Sydney.
131. Rodriguez M.H., Betanzos-Reyes A.F., Hernandez-Avila J.E., Mendez-Galvan J.F., Danis-Lozano R., Altamirano-Jimenez A. The participation of secondary clinical episodes in the epidemiology of vivax malaria during pre- and post-implementation of focal control in the state of Oaxaca, Mexico. Am. J. Trop. Med. Hyg. 2009, 80(6):889-895.
132. Rowland M., Bouma M., Ducornez D., Durrani N., Rozendal J., Schapira A., et al. Pyrethroid-impregnated bed nets for personal protection against malaria for Afghan refugees. Trans. R. Soc. Trop. Med. Hyg. 1996, 90(4):357-361.
133. Ryan J.R., Stoute J.A., Amon J., Dunton R.F., Mtalib R., Koros J., et al. Evidence for transmission of Plasmodium vivax among a duffy antigen negative population in Western Kenya. Am. J. Trop. Med. Hyg. 2006, 75(4):575-581.
134. Sabot O., Cohen J.M., Hsiang M.S., Kahn J.G., Basu S., Tang L., et al. Costs and financial feasibility of malaria elimination. Lancet 2010, 376(9752):1604-1615.
135. Santa-Olalla Peralta P., Vazquez-Torres M.C., Latorre-Fandos E., Mairal-Claver P., Cortina-Solano P., Puy-Azon A., et al. First autochthonous malaria case due to Plasmodium vivax since eradication, Spain, October 2010. Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles (European Communicable Disease Bulletin) 2010, 15(41):19684.
136. Senn N., Rarau P., Manong D., Salib M., Siba P., Robinson L.J., et al. Rapid diagnostic test-based Management of malaria: an effectiveness study in Papua New Guinean infants with Plasmodium falciparum and Plasmodium vivax malaria. Clin. Infect. Dis. 2011.
137. Sergiev V.P., Baranova A.M., Orlov V.S., Mihajlov L.G., Kouznetsov R.L., Neujmin N.I., et al. Importation of malaria into the USSR from Afghanistan, 1981-89. Bull. World Health Organ. 1993, 71(3-4):385-388.
138. Shanks G.D., Edstein M.D., Suriyamongkol V., Timsaad S., Webster H.K. Malaria chemoprophylaxis using proguanil/dapsone combinations on the Thai-Cambodian border. Am. J. Trop. Med. Hyg. 1992, 46(6):643-648.
139. Shanks G.D., Edstein M.D., Kereu R.K., Spicer P.E., Rieckmann K.H. Postexposure administration of halofantrine for the prevention of malaria. Clin. Infect. Dis. 1993, 17(4):628-631.
140. Shanks G.D., Barnett A., Edstein M.D., Rieckmann K.H. Effectiveness of doxycycline combined with primaquine for malaria prophylaxis. Med. J. Aust. 1995, 162(6):306-307. 9-10.
141. Shanks G.D., Roessler P., Edstein M.D., Rieckmann K.H. Doxycycline for malaria prophylaxis in Australian soldiers deployed to United Nations missions in Somalia and Cambodia. Mil. Med. 1995, 160(9):443-445.
142. Shanks G.D., Oloo A.J., Aleman G.M., Ohrt C., Klotz F.W., Braitman D., et al. A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria. Clin. Infect. Dis. 2001, 33(12):1968-1974.
143. Shekalaghe S., ter Braak R., Daou M., Kavishe R., van den Bijilaardt W., van der Bosch S., et al. Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate deyhrogenase-deficient individuals. Antimicrob. Agents Chemother. 2010, 54(5):1762-1768.
144. Shortt H.E., Garnham P.C. Demonstration of a persisting exo-erythrocytic cycle in Plasmodium cynomolgi and its bearing on the production of relapses. Br. Med. J. 1948, 1(4564):1225-1228.
145. Sleigh A.C., Liu X.L., Jackson S., Li P., Shang L.Y. Resurgence of vivax malaria in Henan Province, China. Bull. World Health Organ. 1998, 76(3):265-270.
146. Snowden F.M. The Conquest of Malaria: Italy, 1900-1962 2006, Yale University Press, New Haven.
147. Strangeways-Dixon D. Paludrine (proguanil) as a malarial prophylactic amongst African labour in Kenya. East Afr. Med. J. 1950, 28(3):1-4.
148. Sutanto I., Pribadi W., Purnomo Bandi R., Rusmiarto S., Atmosoedjonon S., et al. Efficacy of permethrin-impregnated bed nets on malaria control in a hyperendemic area in Irian Jaya, Indonesia: influenza of seasonal rainfall fluctuations. Southeast Asian J. Trop. Med. Public Health 1999, 30(3):440-446.
149. Tanner M., de Savigny D. Malaria eradication back on the table. Bull. World Health Organ. 2008, 86(2):82.
150. Tatarsky A., Aboobakar S., Cohen J.M., Gopee N., Bheecarry A., Moonasar D., et al. Preventing the reintroduction of malaria in Mauritius: a programmatic and financial assessment. PloS One 2011, 6(9):e23832.
151. Tatem A.J., Smith D.L., Gething P.W., Kabaria C.W., Snow R.W., Hay S.I. Ranking of elimination feasibility between malaria-endemic countries. Lancet 2010, 376(9752):1579-1591.
152. ter Kuile F.O., van Eijk A.M., Filler S.J. Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. J. Am. Med. Assoc. 2007, 297(23):2603-2616.
153. Toty C., Barre H., Le Goff G., Larget-Thiery I., Rahola N., Couret D., et al. Malaria risk in Corsica, former hot spot of malaria in France. Malar. J. 2010, 9:231.
154. Turkmenistan certified malaria-free. Releve epidemiologique hebdomadaire/Section d'hygiene du Secretariat de la Societe des Nations (Weekly epidemiological record/Health Section of the Secretariat of the League of Nations) 2010, 85(47):461-463.
155. Usenbaev N.T., Ezhov M.N., Zvantsov A.B., Annarbaev A., Zhoroev A.A., Almerekov K. An outbreak of Plasmodium vivax malaria in Kyrghyzstan. Meditsinskaia Parazitologiia I Parazitarnye Bolezni 2006, (1):17-20.
156. Usenbaev N.T., Baranova A.M., Anarbaev A.A., Almerekov K. Experience in sanitizing an urban focus of vivax malaria (Tashkumyr, Kyrghyzstan). Meditsinskaia Parazitologiia I Parazitarnye Bolezni 2008, (3):45-46.
157. Vogel G., Roberts L. Malaria. Vaccine trial meets modest expectations, buoys hopes. Science 2011, 334(6054):298-299.
158. von Seidlein L., Walraven G., Milligan P.J., Alexander N., Manneh F., Deen J.L., et al. The effect of mass administration of sulfadoxine-pyrimethamine combined with artesunate on malaria incidence: a double-blind, community-randomized, placebo-controlled trial in The Gambia. Trans. R. Soc. Trop. Med. Hyg. 2003, 97(2):217-225.
159. Walker A.J. Potentialities of monthly doses of camoquin and a gametocidal drug in malaria control. Trans. R. Soc. Trop. Med. Hyg. 1955, 49(4):351-355.
160. White N.J. Artemisinin resistance-the clock is ticking. Lancet 2010, 376(9758):2051-2052.
161. White N.J. Determinants of relapse periodicity in Plasmodium vivax malaria. Malar. J. 2011, 10:297.
162. Williams L.L. Malaria eradication in the United States. Am. J. Public Health Nations Health 1963, 53:17-21.
163. Xu B.L., Su Y.P., Shang L.Y., Zhang H.W. Malaria control in Henan Province, People's Republic of China. Am. J. Trop. Med. Hyg. 2006, 74(4):564-567.
164. Yeom J.S., Ryu S.H., Oh S., Choi D.H., Song K.J., Oh Y.H., et al. Evaluation of anti-malarial effects of mass chemoprophylaxis in the Republic of Korea army. J. Korean Med. Sci. 2005, 20(5):707-712.
165. Yip K. Antimalarial work in China: a historical perspective. Parassitologia 1998, 40(1-2):29-38.
166. Yip K. Malaria eradication: the Taiwan experience. Parassitologia 2000, 42:117-126.
167. Zhang X.B., Deng D. An epidemiological study of the residual vivax malaria cases in Huanghuai plain. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi (Chinese Journal of Parasitology & Parasitic Diseases) 1989, 7(1):22-27.
168. Zhou H.Y., Wang W.M., Cao J., Zhu G.D., Gao Q. Epidemiological analysis of malaria situation in Jiangsu Province in 2009. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi (Chinese Journal of Schistosomiasis Control) 2011, 23(4):402-405.
169. Zoungrana A., Coulibaly B., Sie A., Walter-Sack I., Mockenhaupt F.P., Kouyate B., et al. Safety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso. PloS One 2008, 3(2). e1630.
170. Zucker J. Changing patterns of autochthonous malaria transmission in the United States: a review of recent outbreaks. Emerg. Infect. Dis. 1996, 2(1):37-43.